Erratum: Antioxidant effect of carnosine treatment on renal oxidative stress in streptozotocin-induced diabetic rats (Biotechnic and Histochemistry (2014) 89 (552-557) DOI: 10.3109/10520295.2014.913811);Antioxidant effect of carnosine treatment on renal oxidative stress in streptozotocin-induced diabetic rats

Biotechnic and Histochemistry

Volumn 89, Issue 8, 2014, Pages 552-557

  Yay, A ^a   Akkus D ^a   Yapislar, H ^b   Balcioglu, E ^a   Sonmez, M F ^a   Ozdamar, S ^a  

^a ERCIYES UNIVERSITY   (Turkey)

^b ISTANBUL BILIM UNIVERSITY   (Turkey)

Author keywords

Antioxidant therapy; Carnosine; Diabetes; ENOS; Kidney; Nephropathy

Indexed keywords

RATTUS;

ANTIOXIDANT; CARNOSINE; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN;

ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; KIDNEY; KIDNEY DISEASES; MALE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; RAT; TREATMENT OUTCOME; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; CARNOSINE; DIABETES MELLITUS, EXPERIMENTAL; KIDNEY; KIDNEY DISEASES; MALE; OXIDATIVE STRESS; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; STREPTOZOCIN; TREATMENT OUTCOME;

EID: 84911491773     PISSN: 10520295     EISSN: 14737760     Source Type: Journal    
DOI: 10.3109/10520295.2015.1030921     Document Type: Erratum

References (37)

1. Ansurudeen I., Sunkari VG., Gr ü nler J., Peters V., Schmitt CP., Catrina SB., Brismar K., Forsberg EA (2012) Carnosine enhances diabetic wound healing in the db/db mouse model of type 2 diabetes. Amino Acids 43 : 127-134
2. Armstrong D., Al-Awadi F (1991) Lipid peroxidation and retinopathy in streptozotocin induced diabetes. Free Rad. Biol. Med. 11 : 433-436
3. Aydogan S., Yapislar H., Artis S., Aydogan B (2008). Impaired erythrocytes deformability in H(2)O(2)-induced oxidative stress: protective effect of L-carnosine. Clin. Hemorheol. Microcirc. 39 : 93-98
4. Baynes JW., Thorpe SR (1999) Role of oxidative stress in Diabetic complications: a new perspective on an old paradigm. Diabetes 48 : 1-9
5. Browmlee M (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414 : 813-820
6. Ceriello A (2000) Oxidative stress and glycemic regulation. Metabolism 49 : 27-29
7. Dellamea BS., Leitäo CB., Friedman R., Canani LH (2014). Nitric oxide system and diabetic nephropathy. Diabetol. Metab. Syndrome 6 : 17-22
8. Eleftheriadis T., Antoniadi G., Pissas G., Liakopoulos V., Stefanidis I (2013) The renal endothelium in Diabetic nephropathy. Ren. Fail. 35 : 592-599
9. Fioretto P., Mauer M (2007) Histopathology of diabetic nephropathy. Semin. Nephrol. 27 : 195-207
10. Freedman BI., Hicks PJ., Sale MM., Pierson ED., Langefeld CD., Rich SS., Xu J., McDonough C., Janssen B., Yard BA., van Der Woude FJ., Bowden DW (2007) A leucine repeat in the carnosinase gene CNDP1 is associated with diabetic end-stage renal disease in European Americans. Nephrol. Dial. Transplant. 22: 1131-1135
11. Gang JK., Young SK., Sang YH., Mi Hwa L., Hye K., Kum H., Dae R (2008) Lioglitazone attenuates diabetic nephropathy through an anti-infl ammatory mechanism in type 2 diabetic rats. Nephrol. Dial. Transplant. 23: 2750-2760
12. Ha H., Kim KH (1999) Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C.Diabetes Res. Clin. Pract. 45 : 147-151
13. Ha H., Lee SH., Kim KH (1997) Effects of rebamipide in a model of experimental diabetes and on the synthesis of transforming growth factor-b and fi bronectin, lipid peroxidation induced by high glucose in cultured mesangial cells. J. Pharmacol. Exp. Ther. 281 : 1457-1462
14. Hipkiss AR., Brownson C., Carrier MJ (2001) Carnosine, the anti-Aging, antioxidant dipeptide, may react with protein carbonyl groups. Mech. Ageing Dev. 122 : 1431-1445
15. Ibrahim HN., Hostetter TH (1997) Diabetic nephropathy.J. Am. Soc. Nephrol. 8 : 487-493
16. Isermann B., Vinnikov IA., Madhusudhan T., Herzog S., Kashif M., Blautzik J., Corat MA., Zeier M., Blessing E., Oh J., Gerlitz B., Berg DT., Grinnell BW., Chavakis T., Esmon CT., Weiler H., Bierhaus A., Nawroth PP (2007) Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis. Nat. Med. 13: 1349-1358
17. Janssen B., Hohenadel D., Brinkkoetter P., Peters V., Rind N., Fischer C., Rychlik I., Cerna M., Romzova M., de Heer E., Baelde H., Bakker SJ., Zirie M., Rondeau E., Mathieson P., Saleem MA., Meyer J., K ö ppel H., Sauerhoefer S., Bartram CR., Nawroth P., Hammes HP., Yard BA., Zschocke J., van Der Woude FJ (2005) Carnosine as a protective factor in Diabetic nephropathy. Diabetes 54 : 2320-2327
18. Kalousová M., Skrha J., Zima T (2002) Advanced glycation end products and advanced oxidation protein products in patients with diabetes mellitus. Physiol. Res. 51 : 597-604
19. Lee YT., Hsu CC., Lin MH., Liu KS., Yin MC (2005) Histidine and carnosine delay diabetic deterioration in mice and protect human low density lipoprotein against oxidation and glycation. Eur. J. Pharmacol. 513 : 145-150
20. Mensah-Brown EP., Obineche EN., Galadari S., Chandranath E., Shahin A., Ahmed I., Patel SM., Adem A (2005) Streptozotocin-induced diabetic nephropathy in rats: the role of infl ammatory cytokines. Cytokine 31: 180-190
21. Mojica-Villegas MA., Izquierdo-Vega JA., Chamorro-Cevallos G., and Sá nchez-Guti é rrez M (2014) Protective effect of resveratrol on biomarkers of oxidative stress induced by iron/ascorbate in mouse spermatozoa. Nutrients 6 : 489-503
22. Nobrega MA., Fleming S., Roman RJ., Shiozawa M., Schlick N., Lazar J., Jacob HJ (2004) Initial characterization of a rat model of diabetic nephropathy. Diabetes 53 : 735-742
23. Ohkubo Y., Kishikawa H., Araki E., Miyata T., Isami S., Motoyoshi S., Kojima Y., Furuyoshi N., Shichiri M (1995). Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res. Clin. Pract. 28: 103-117
24. Ozbek E (2012) Induction of oxidative stress in kidney.Int. J. Nephrol. 2012 : 465897
25. Pall M (2013) The NO/ONOO - cycle as the central cause of heart failure. Int. J. Mol. Sci. 14 : 22274-22330
26. Pitocco D., Zaccardi F., Di Stasio E., Romitelli F., Santini SA., Zuppi C., Ghirlanda G ( 2010 ) Oxidative stress, nitric oxide, and diabetes. Rev. Diabet. Stud. 7 : 15-25
27. Rashid I., van Reyk DM., Davies MJ (2007) Carnosine and its constituents inhibit glycation of low-density lipoproteins that promotes foam cell formation in vitro. FEBS Lett. 581 : 1067-070
28. Riedl E., Pfi ster F., Braunagel M., Brinkk ö tter P., Sternik P., Deinzer M., Bakker SJ., Henning RH., van Den Born J., Krämer BK., Navis G., Hammes HP., Yard B., Koeppel H (2011) Carnosine prevents apoptosis of glomerular cells and podocyte loss in STZ diabetic rats.Cell Physiol. Biochem. 28 : 279-288
29. Ruiz-Munoz LM., Vidal VF., Lamreabe I (1997) Enaraplilat inhibits hydrogen peroxide production by murine mesangial cells exposed to high glucose concentrations.Nephrol. Dial. Transplant. 12 : 456-464
30. Sauerhöfer S., Yuan G., Braun GS., Deinzer M., Neumaier M., Gretz N., Floege J., Kriz W., van Der Woude F., Moeller MJ (2007) L-carnosine, a substrate of carnosinase-1, infl uences glucose metabolism. Diabetes 56: 2425-2432
31. Severina IS., Bussygina OG., Pyatakova NV (2000). Carnosine as a regulator of soluble guanylate cyclase.Biochemistry (Moscow) 65 : 921-927
32. Shah SV, Baliga R, Rajapurkar M, Fonseca VA (2007). Oxidants in Chronic Kidney Disease. J. Am. Soc. Nephrol. 18: 16-28
33. Sugano M., Yamato H., Hayashi T., Ochiai H., Kakuchi J., Goto S., Nishijima F., Iino N., Kazama JJ., Takeuchi T., Mokuda O., Ishikawa T., Okazaki R (2006) High-fat diet in low dose streptozotocin-Treated heminephrectomized rats induced all features of human type 2 diabetic nephropathy: a new rat model of diabetic nephropathy. Nutr. Metab. Cardiovasc. Dis. 16 : 477-484
34. Sun L., Halaihel N., Zhang W., Rogers T., Levi M (2002) Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in Diabetes mellitus. J. Biol. Chem. 277 : 18919-18927
35. Suzuki S., Hinokio Y., Komatu K., Ohtomo M., Onoda M., Hirai S., Hirai M., Hirai A., Chiba M., Kasuga S., Akai H., Toyota T (1999) Oxidative damage to mitochondrial DNA and its relationship to diabetic complications. Diabetes Res. Clin. Pract. 45 : 161-168
36. Yapislar H., Aydogan S (2012) Effect of carnosine on erythrocyte deformability in Diabetic rats. Arch. Physiol. Biochem. 118 : 265-272
37. Yusong Y., Rajendra S., Abha S., Sanjay A., Yogesh CA (2003) Lipid peroxidation and cell cycle signaling: 4-hydroxynonenal, a key molecule in stress mediated signaling. Acta Biochim. Polon. 50 : 319-336